Why the study?
Does intracoronary thrombolytic reperfusion reduce mortality and improve clinical markers in patients with early acute transmural myocardial infarction?
Population
Patients with early acute transmural myocardial infarction
Comparison
Intracoronary thrombolytic reperfusion vs Nonreperfused patients
Design
Review
Key result
Early thrombolytic reperfusion appears beneficial in acute transmural myocardial infarction, although markers of success or failure do not necessarily correlate with short-term mortality.
Authors
Loading...
Early thrombolysis may benefit transmural MI; leaves open whether reperfusion markers predict mortality.
Does intracoronary thrombolytic reperfusion reduce mortality and improve clinical markers in patients with early acute transmural myocardial infarction?
This review suggests that early intracoronary thrombolytic reperfusion is beneficial for acute transmural myocardial infarction, though surrogate markers may not predict short-term mortality.
DeWood et al. (2008) conducted a review in Acute transmural myocardial infarction. Thrombolytic therapy vs. Nonreperfused patients was evaluated on Mortality and markers of success or failure. Early thrombolytic reperfusion appears beneficial in acute transmural myocardial infarction, although markers of success or failure do not necessarily correlate with short-term mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: